[Infectious endocarditis caused by Escherichi coli].
Valencia
M E
ME
Guinea
J
J
Enríquez
A
A
González-Lahoz
J
J
D000328:Adult; D016470:Bacteremia / Q000150:complications / Q000382:microbiology; D002439:Cefotaxime / Q000627:therapeutic use; D003023:Cloxacillin / Q000627:therapeutic use; D004352:Drug Resistance, Microbial; D004359:Drug Therapy, Combination / Q000627:therapeutic use; D004697:Endocarditis, Bacterial / Q000188:drug therapy / Q000209:etiology / Q000382:microbiology*; D004926:Escherichia coli / Q000187:drug effects / Q000302:isolation & purification*; D004927:Escherichia coli Infections / Q000188:drug therapy / Q000209:etiology; D017809:Fatal Outcome; D005260:Female; D015658:HIV Infections / Q000150:complications; D006801:Humans; D007275:Injections, Intravenous / Q000009:adverse effects; D008297:Male; D015819:Substance Abuse, Intravenous / Q000150:complications*; D014031:Tobramycin / Q000627:therapeutic use; D014552:Urinary Tract Infections / Q000150:complications / Q000382:microbiology
D002439:Cefotaxime; D003023:Cloxacillin; D014031:Tobramycin